• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cadre Holdings Reports Fourth Quarter and Full Year 2025 Financial Results

    3/10/26 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email

    Generated Annual Net Sales of $610.3 Million, Gross Margin of 42.5% and Net Income of $44.1 Million

    Achieved Record Annual Adjusted EBITDA for Third Consecutive Year

    Expects Full Year 2026 Net Sales of $736 to $758 Million and Adjusted EBITDA of $136 to $141 Million, Reflecting Year-Over-Year Growth of 22% and 24%, Respectively, at Midpoints

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the quarter and year ended December 31, 2025.

    • Net sales of $167.2 million for the fourth quarter; net sales of $610.3 million for the year ended December 31, 2025.
    • Gross profit margin of 43.4% for the fourth quarter; gross profit margin of 42.5% for the year ended December 31, 2025.
    • Net income of $11.7 million, or $0.27 per diluted share, for the fourth quarter; net income of $44.1 million, or $1.02 per diluted share, for the year ended December 31, 2025.
    • Adjusted EBITDA of $34.4 million for the fourth quarter; adjusted EBITDA of $111.7 million for the year ended December 31, 2025.
    • Adjusted EBITDA margin of 20.6% for the fourth quarter; adjusted EBITDA margin of 18.3% for the year ended December 31, 2025.
    • Declared quarterly cash dividend of $0.10 per share in January 2026. On an annualized basis, this dividend represents an increase of $0.02 per share, or 5.3% per share, over the previous annualized dividend of $0.38 per share.

    "2025 marked another year of strong financial and strategic progress for Cadre, underscoring the resilience of our businesses, the market leadership of our brands, and the consistency of our teams' execution," said Warren Kanders, CEO and Chairman. "We continued to see strong and recurring demand throughout the year for our suite of leading safety products across our law enforcement, first responder, military and nuclear categories. We delivered higher net sales and profit in 2025, as well as record adjusted EBITDA, while expanding full year gross margin 140 basis points year-over-year. The Cadre operating model drives improvement every day, and we are excited about the potential to unlock further efficiencies and profitability moving forward."

    Mr. Kanders added, "Cadre maintains a relentless focus on disciplined M&A, and we are pleased to have capitalized on two more highly attractive opportunities in 2025. Following the acquisition of Carr's Engineering Division in April, which added scale and a broader international footprint to our nuclear vertical, we took steps to further enhance Cadre's leadership in our core market with the addition of TYR Tactical. A leading provider of plate carriers, vests, hard armor, and shields to tactical teams, TYR has world-class engineering capabilities and a global reach. Looking ahead, we have a robust acquisition pipeline in both the public safety and nuclear markets and intend to continue to grow our diversified portfolio of mission-critical safety businesses through patient and disciplined capital allocation."

    Fourth Quarter and Year-End 2025 Operating Results

    For the quarter ended December 31, 2025, Cadre generated net sales of $167.2 million, as compared to $176.0 million for the quarter ended December 31, 2024. This decrease was primarily a result of higher than normal shipments in the prior year due to the cyber incident in the third quarter of 2024.

    For the year ended December 31, 2025, Cadre generated net sales of $610.3 million, as compared to $567.6 million for the year ended December 31, 2024, mainly driven by recent acquisitions and higher demand for duty gear products, partially offset by a decline in EOD products and existing nuclear safety products.

    For the quarter ended December 31, 2025, Cadre generated gross profit of $72.6 million, as compared to $77.2 million for the quarter ended December 31, 2024. For the year ended December 31, 2025, Cadre generated gross profit of $259.6 million, as compared to $233.5 million for the prior year period.

    Gross profit margin was 43.4% for the quarter ended December 31, 2025, as compared to 43.9% for the quarter ended December 31, 2024, mainly driven by lower volumes and an increase in inventory step-up amortization, partially offset by favorable pricing net of material inflation. Gross profit margin was 42.5% for the year ended December 31, 2025, as compared to 41.1% for the prior year period.

    Net income was $11.7 million for the quarter ended December 31, 2025, as compared to net income of $13.0 million for the quarter ended December 31, 2024, primarily as a result of decreased gross profit year over year.

    Net income was $44.1 million for the year ended December 31, 2025, as compared to net income of $36.1 million for the prior year period, primarily as a result of increased gross profit, partially offset by increases in selling, general and administrative expenses from acquisitions, acquisition related costs, interest expense, and stock compensation expense.

    Cadre generated $34.4 million of adjusted EBITDA for the quarter ended December 31, 2025, as compared to $38.5 million for the quarter ended December 31, 2024. Adjusted EBITDA margin was 20.6% for the quarter ended December 31, 2025, as compared to 21.9% for the prior year period.

    Cadre generated $111.7 million of adjusted EBITDA for the year ended December 31, 2025, as compared to $104.8 million for the prior period. Adjusted EBITDA margin was 18.3% for the year ended December 31, 2025, as compared to 18.5% for the prior year period.

    Product segment gross margin was 44.2% and 43.5% for the fourth quarter and full year of 2025, respectively, compared to 45.4% and 42.2% for the prior year periods.

    Distribution segment gross margin was 21.9% and 22.0% for the fourth quarter and full year of 2025, respectively, compared to 21.8% and 22.5% for the prior year periods.

    Liquidity, Cash Flows and Capital Allocation

    • Cash and cash equivalents decreased by $2.0 million from $124.9 million as of December 31, 2024 to $122.9 million as of December 31, 2025.
    • Total debt increased by $84.1 million from $223.2 million as of December 31, 2024 to $307.3 million as of December 31, 2025.
    • Net debt (total debt net of cash and cash equivalents) increased by $86.1 million from $98.3 million as of December 31, 2024 to $184.4 million as of December 31, 2025.
    • Capital expenditures totaled $3.4 million for the fourth quarter and $7.0 million for the year ended December 31, 2025, compared with $1.4 million for the fourth quarter and $5.8 million for the year ended December 31, 2024.

    Acquisition of TYR Tactical

    On January 30, 2026, Cadre completed its acquisition of TYR Tactical, LLC, a leading global manufacturer of tactical gear and equipment for military, law enforcement, and government agencies worldwide. The addition of TYR Tactical is expected to be immediately accretive to earnings and adjusted EBITDA margins.

    Increased Dividend

    On January 20, 2026, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, or $0.40 per share on an annualized basis, which represents an increase of $0.02 per share, or 5.3% per share, over the previous annualized dividend of $0.38 per share. Cadre's dividend payment was made on February 13, 2026 to shareholders of record as of the close of business on the record date of January 30, 2026. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.

    2026 Outlook

    For the full year 2026, Cadre expects to generate net sales in the range of $736 million to $758 million and adjusted EBITDA in the range of $136 million and $141 million. We expect capital expenditures to be in the range of $10 million to $14 million. Cadre has not provided net income guidance due to the inherent difficulty of forecasting certain types of expenses and gains, which affect net income but not adjusted EBITDA. Therefore, we do not provide a reconciliation of adjusted EBITDA guidance to net income guidance.

    Conference Call

    Management will host a conference call on Wednesday, March 11, 2026, at 10:00 a.m. EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (800)-715-9871 and the dial-in number for international callers is 646-307-1963. The access code for all callers is 9511718. A live webcast will also be available on the Company's website at https://www.cadre-holdings.com/.

    A replay of the call will be available through March 25, 2026. To access the replay, please dial 800-770-2030 in the U.S. or +1-609-800-9909 if outside the U.S., and then enter the access code 9511718.

    About Cadre

    Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety products. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.

    Use of Non-GAAP Measures

    The Company reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization ("EBITDA"), (ii) adjusted EBITDA and (iii) adjusted EBITDA margin. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user's overall understanding of the Company's current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. We do not provide a reconciliation of the non-GAAP guidance measure adjusted EBITDA for the fiscal year 2026 to net income for the fiscal year 2026, the most comparable GAAP financial measure, due to the inherent difficulty of forecasting certain types of expenses and gains, without unreasonable effort, which affect net income but not adjusted EBITDA. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company's reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

    Forward-Looking Statements

    Please note that in this press release we may use words such as "appears," "anticipates," "believes," "plans," "expects," "intends," "future," and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this press release, include, but are not limited to, those risks and uncertainties more fully described from time to time in the Company's public reports filed with the Securities and Exchange Commission, including under the section titled "Risk Factors" in the Company's Annual Report on Form 10-K, and/or Quarterly Reports on Form 10-Q, as well as in the Company's Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release and speak only as of the date hereof. We assume no obligation to update any forward- looking statements to reflect events or circumstances after the date of this press release.

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

     

    December 31, 2025

     

    December 31, 2024

    Assets

     

     

     

     

     

     

    Current assets

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    122,898

     

    $

    124,933

     

    Restricted cash

     

     

    2,429

     

     

    —

     

    Accounts receivable, net

     

     

    110,607

     

     

    93,523

     

    Inventories

     

     

    100,263

     

     

    82,351

     

    Prepaid expenses

     

     

    14,574

     

     

    19,027

     

    Other current assets

     

     

    15,095

     

     

    7,737

     

    Total current assets

     

     

    365,866

     

     

    327,571

     

    Property and equipment, net

     

     

    78,822

     

     

    45,243

     

    Operating lease assets

     

     

    19,778

     

     

    15,454

     

    Deferred tax assets, net

     

     

    4,816

     

     

    4,552

     

    Intangible assets, net

     

     

    114,984

     

     

    107,544

     

    Goodwill

     

     

    181,406

     

     

    148,157

     

    Other assets

     

     

    4,359

     

     

    4,192

     

    Total assets

     

    $

    770,031

     

    $

    652,713

     

     

     

     

     

     

     

     

    Liabilities, Mezzanine Equity and Shareholders' Equity

     

     

     

     

     

     

    Current liabilities

     

     

     

     

     

     

    Accounts payable

     

    $

    22,325

     

    $

    29,644

     

    Accrued liabilities

     

     

    61,066

     

     

    46,413

     

    Income tax payable

     

     

    4,838

     

     

    6,693

     

    Current portion of long-term debt

     

     

    16,266

     

     

    11,375

     

    Total current liabilities

     

     

    104,495

     

     

    94,125

     

    Long-term debt

     

     

    290,987

     

     

    211,830

     

    Long-term operating lease liabilities

     

     

    15,039

     

     

    10,733

     

    Deferred tax liabilities

     

     

    30,058

     

     

    18,758

     

    Other liabilities

     

     

    11,648

     

     

    5,752

     

    Total liabilities

     

     

    452,227

     

     

    341,198

     

     

     

     

     

     

     

     

    Mezzanine equity

     

     

     

     

     

     

    Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2025 and December 31, 2024)

     

     

    —

     

     

    —

     

     

     

     

     

     

     

     

    Shareholders' equity

     

     

     

     

     

     

    Common stock ($0.0001 par value, 190,000,000 shares authorized, 42,160,656 and 40,607,988 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively)

     

     

    4

     

     

    4

     

    Additional paid-in capital

     

     

    282,570

     

     

    306,821

     

    Accumulated other comprehensive income (loss)

     

     

    460

     

     

    (1,389

    )

    Accumulated earnings

     

     

    34,770

     

     

    6,079

     

    Total shareholders' equity

     

     

    317,804

     

     

    311,515

     

    Total liabilities, mezzanine equity and shareholders' equity

     

    $

    770,031

     

    $

    652,713

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended December 31,

     

    Year Ended December 31,

     

     

    2025

     

    2024

     

    2025

     

    2024

    Net sales

     

    $

    167,224

     

     

    $

    175,984

     

     

    $

    610,308

     

     

    $

    567,561

     

    Cost of goods sold

     

     

    94,601

     

     

     

    98,797

     

     

     

    350,680

     

     

     

    334,080

     

    Gross profit

     

     

    72,623

     

     

     

    77,187

     

     

     

    259,628

     

     

     

    233,481

     

    Operating expenses

     

     

     

     

     

     

     

     

     

     

     

     

    Selling, general and administrative

     

     

    50,619

     

     

     

    45,046

     

     

     

    183,128

     

     

     

    158,323

     

    Restructuring and transaction costs

     

     

    1,456

     

     

     

    2,386

     

     

     

    7,696

     

     

     

    6,007

     

    Related party expense

     

     

    108

     

     

     

    352

     

     

     

    1,453

     

     

     

    2,390

     

    Total operating expenses

     

     

    52,183

     

     

     

    47,784

     

     

     

    192,277

     

     

     

    166,720

     

    Operating income

     

     

    20,440

     

     

     

    29,403

     

     

     

    67,351

     

     

     

    66,761

     

    Other expense

     

     

     

     

     

     

     

     

     

     

     

     

    Interest expense, net

     

     

    (3,631

    )

     

     

    (2,191

    )

     

     

    (12,480

    )

     

     

    (7,822

    )

    Other income (expense), net

     

     

    856

     

     

     

    (4,496

    )

     

     

    7,455

     

     

     

    (4,721

    )

    Total other expense, net

     

     

    (2,775

    )

     

     

    (6,687

    )

     

     

    (5,025

    )

     

     

    (12,543

    )

    Income before provision for income taxes

     

     

    17,665

     

     

     

    22,716

     

     

     

    62,326

     

     

     

    54,218

     

    Provision for income taxes

     

     

    (5,926

    )

     

     

    (9,733

    )

     

     

    (18,187

    )

     

     

    (18,085

    )

    Net income

     

    $

    11,739

     

     

    $

    12,983

     

     

    $

    44,139

     

     

    $

    36,133

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income per share:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

    $

    0.28

     

     

    $

    0.32

     

     

    $

    1.08

     

     

    $

    0.90

     

    Diluted

     

    $

    0.27

     

     

    $

    0.32

     

     

    $

    1.02

     

     

    $

    0.90

     

    Weighted average shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

     

    41,511,999

     

     

     

    40,607,988

     

     

     

    40,866,776

     

     

     

    39,945,982

     

    Diluted

     

     

    43,296,723

     

     

     

    40,977,622

     

     

     

    43,432,872

     

     

     

    40,332,042

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

    Year Ended December 31,

     

     

    2025

     

    2024

     

    2023

    Cash Flows From Operating Activities:

     

     

     

     

     

     

     

     

     

    Net income

     

    $

    44,139

     

     

    $

    36,133

     

     

    $

    38,641

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    18,633

     

     

     

    16,420

     

     

     

    15,737

     

    Amortization of original issue discount and debt issue costs

     

     

    1,321

     

     

     

    1,109

     

     

     

    479

     

    Amortization of inventory step-up

     

     

    1,296

     

     

     

    3,858

     

     

     

    —

     

    Deferred income taxes

     

     

    2,388

     

     

     

    (2,064

    )

     

     

    (210

    )

    Stock-based compensation

     

     

    12,239

     

     

     

    8,369

     

     

     

    9,368

     

    Remeasurement of contingent consideration

     

     

    1,927

     

     

     

    1,185

     

     

     

    —

     

    (Recoveries from) provision for losses on accounts receivable

     

     

    (108

    )

     

     

    764

     

     

     

    66

     

    Unrealized foreign exchange transaction (gain) loss

     

     

    (2,356

    )

     

     

    1,880

     

     

     

    (602

    )

    Other loss (gain)

     

     

    390

     

     

     

    496

     

     

     

    (381

    )

    Changes in operating assets and liabilities, net of impact of acquisitions:

     

     

     

     

     

     

     

     

     

    Accounts receivable

     

     

    8,363

     

     

     

    (24,902

    )

     

     

    6,602

     

    Inventories

     

     

    (3,617

    )

     

     

    10,019

     

     

     

    (10,223

    )

    Prepaid expenses and other assets

     

     

    (4,503

    )

     

     

    (5,866

    )

     

     

    (302

    )

    Accounts payable and other liabilities

     

     

    (16,407

    )

     

     

    (15,624

    )

     

     

    14,034

     

    Net cash provided by operating activities

     

     

    63,705

     

     

     

    31,777

     

     

     

    73,209

     

    Cash Flows From Investing Activities:

     

     

     

     

     

     

     

     

     

    Purchase of property and equipment

     

     

    (6,856

    )

     

     

    (5,668

    )

     

     

    (6,727

    )

    Proceeds from disposition of property and equipment

     

     

    77

     

     

     

    55

     

     

     

    207

     

    Business acquisitions, net of cash acquired

     

     

    (89,590

    )

     

     

    (141,813

    )

     

     

    —

     

    Net cash used in investing activities

     

     

    (96,369

    )

     

     

    (147,426

    )

     

     

    (6,520

    )

    Cash Flows From Financing Activities:

     

     

     

     

     

     

     

     

     

    Proceeds from revolving credit facilities

     

     

    —

     

     

     

    5,500

     

     

     

    —

     

    Principal payments on revolving credit facilities

     

     

    —

     

     

     

    (5,500

    )

     

     

    —

     

    Proceeds from term loans

     

     

    97,500

     

     

     

    129,422

     

     

     

    —

     

    Principal payments on term loans

     

     

    (13,823

    )

     

     

    (43,334

    )

     

     

    (10,000

    )

    Proceeds from insurance premium financing

     

     

    —

     

     

     

    —

     

     

     

    3,949

     

    Principal payments on insurance premium financing

     

     

    —

     

     

     

    (2,187

    )

     

     

    (3,973

    )

    Payments for debt issuance costs

     

     

    —

     

     

     

    (3,105

    )

     

     

    —

     

    Taxes paid in connection with employee stock transactions

     

     

    (40,227

    )

     

     

    (5,311

    )

     

     

    (2,725

    )

    Proceeds from exercise of stock options

     

     

    3,377

     

     

     

    —

     

     

     

    —

     

    Proceeds from secondary offering, net of underwriter discounts

     

     

    —

     

     

     

    91,776

     

     

     

    —

     

    Deferred offering costs

     

     

    —

     

     

     

    (683

    )

     

     

    —

     

    Dividends distributed

     

     

    (15,448

    )

     

     

    (13,948

    )

     

     

    (12,006

    )

    Other

     

     

    207

     

     

     

    37

     

     

     

    33

     

    Net cash provided by (used in) financing activities

     

     

    31,586

     

     

     

    152,667

     

     

     

    (24,722

    )

    Effect of foreign exchange rates on cash, cash equivalents and restricted cash

     

     

    1,472

     

     

     

    224

     

     

     

    438

     

    Change in cash, cash equivalents and restricted cash

     

     

    394

     

     

     

    37,242

     

     

     

    42,405

     

    Cash, cash equivalents and restricted cash, beginning of period

     

     

    124,933

     

     

     

    87,691

     

     

     

    45,286

     

    Cash, cash equivalents and restricted cash, end of period

     

    $

    125,327

     

     

    $

    124,933

     

     

    $

    87,691

     

    Supplemental Disclosure of Cash Flows Information:

     

     

     

     

     

     

     

     

     

    Cash paid for income taxes, net

     

    $

    24,920

     

     

    $

    24,207

     

     

    $

    8,729

     

    Cash paid for interest

     

    $

    17,842

     

     

    $

    14,431

     

     

    $

    10,090

     

    Supplemental Disclosure of Non-Cash Investing and Financing Activities:

     

     

     

     

     

     

     

     

     

    Accruals and accounts payable for capital expenditures

     

    $

    139

     

     

    $

    176

     

     

    $

    234

     

    CADRE HOLDINGS, INC.

    SEGMENT INFORMATION

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended December 31, 2025

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    152,054

     

    $

    25,051

     

    $

    (9,881

    )

     

    $

    167,224

    Cost of goods sold

     

     

    84,867

     

     

    19,553

     

     

    (9,819

    )

     

     

    94,601

    Gross profit

     

    $

    67,187

     

    $

    5,498

     

    $

    (62

    )

     

    $

    72,623

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended December 31, 2024

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    153,913

     

    $

    33,782

     

    $

    (11,711

    )

     

    $

    175,984

    Cost of goods sold

     

     

    84,093

     

     

    26,415

     

     

    (11,711

    )

     

     

    98,797

    Gross profit

     

    $

    69,820

     

    $

    7,367

     

    $

    —

     

     

    $

    77,187

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Year Ended December 31, 2025

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    543,713

     

    $

    104,904

     

    $

    (38,309

    )

     

    $

    610,308

    Cost of goods sold

     

     

    307,056

     

     

    81,846

     

     

    (38,222

    )

     

     

    350,680

    Gross profit

     

    $

    236,657

     

    $

    23,058

     

    $

    (87

    )

     

    $

    259,628

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Year Ended December 31, 2024

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    497,624

     

    $

    105,397

     

    $

    (35,460

    )

     

    $

    567,561

    Cost of goods sold

     

     

    287,864

     

     

    81,631

     

     

    (35,415

    )

     

     

    334,080

    Gross profit

     

    $

    209,760

     

    $

    23,766

     

    $

    (45

    )

     

    $

    233,481

    _______________________

    (1)

    Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.

    CADRE HOLDINGS, INC.

    RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended December 31,

     

    Year Ended December 31,

     

     

     

    2025

     

    2024

     

    2025

     

    2024

     

    Net income

     

    $

    11,739

     

    $

    12,983

     

    $

    44,139

     

    $

    36,133

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    4,725

     

     

    4,095

     

     

    18,633

     

     

    16,420

     

    Interest expense, net

     

     

    3,631

     

     

    2,191

     

     

    12,480

     

     

    7,822

     

    Provision for income taxes

     

     

    5,926

     

     

    9,733

     

     

    18,187

     

     

    18,085

     

    EBITDA

     

    $

    26,021

     

    $

    29,002

     

    $

    93,439

     

    $

    78,460

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and transaction costs(1)

     

     

    1,456

     

     

    2,386

     

     

    8,696

     

     

    7,757

     

    Other expense (income), net(2)

     

     

    (856)

     

     

    4,496

     

     

    (7,455)

     

     

    4,721

     

    Stock-based compensation expense(3)

     

     

    5,399

     

     

    2,114

     

     

    12,239

     

     

    8,369

     

    Stock-based compensation payroll tax expense(4)

     

     

    1,474

     

     

    —

     

     

    1,566

     

     

    441

     

    LTIP bonus(5)

     

     

    —

     

     

    —

     

     

    —

     

     

    49

     

    Amortization of inventory step-up(6)

     

     

    470

     

     

    7

     

     

    1,296

     

     

    3,858

     

    Contingent consideration expense(7)

     

     

    438

     

     

    500

     

     

    1,927

     

     

    1,185

     

    Adjusted EBITDA

     

    $

    34,402

     

    $

    38,505

     

    $

    111,708

     

    $

    104,840

     

    Adjusted EBITDA margin(8)

     

     

    20.6

    %

     

    21.9

    %

     

    18.3

    %

     

    18.5

    %

    _______________________

    (1)

    Reflects the "Restructuring and transaction costs" line item on our consolidated statements of operations and comprehensive income, which primarily includes transaction costs composed of legal and consulting fees. In addition, this line item reflects a $1.0 million fee paid to Kanders & Company, Inc. for services related to the acquisition of Zircaloy for the year ended December 31, 2025 and fees of $1.8 million and $0.3 million paid to Kanders & Company, Inc. for services related to the acquisition of Alpha Safety and execution of our debt refinancing, respectively, for the year ended December 31, 2024, which are included in related party expense in the Company's consolidated statements of operations.

    (2)

    Reflects the "Other income (expense), net" line item on our condensed consolidated statements of operations and primarily includes transaction gains and losses due to fluctuations in foreign currency exchange rates.

    (3)

    Reflects compensation expense related to equity classified stock-based compensation plans.

    (4)

    Reflects payroll taxes associated with vested stock-based compensation awards.

    (5)

    Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.

    (6)

    Reflects amortization expense related to the step-up inventory adjustment recorded as a result of our recent acquisitions.

    (7)

    Reflects contingent consideration expense related to the acquisition of ICOR.

    (8)

    Reflects adjusted EBITDA / net sales for the relevant periods.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260310992578/en/

    Gray Hudkins

    Cadre Holdings, Inc.

    203-550-7148

    [email protected]



    Investor Relations:

    The IGB Group

    Leon Berman / Matt Berkowitz

    212-477-8438 / 212-227-7098

    Get the next $CDRE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    8/13/2025$26.00Neutral → Underperform
    BofA Securities
    6/13/2025$38.00Buy → Neutral
    BofA Securities
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    More analyst ratings

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cadre Holdings Reports Fourth Quarter and Full Year 2025 Financial Results

    Generated Annual Net Sales of $610.3 Million, Gross Margin of 42.5% and Net Income of $44.1 Million Achieved Record Annual Adjusted EBITDA for Third Consecutive Year Expects Full Year 2026 Net Sales of $736 to $758 Million and Adjusted EBITDA of $136 to $141 Million, Reflecting Year-Over-Year Growth of 22% and 24%, Respectively, at Midpoints Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the quarter and year ended December 31, 2025. Net sales of $1

    3/10/26 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Subsidiary Is Awarded $86 Million in Contracts by General Dynamics European Land Systems

    Company will Provide Life-Saving Blast Attenuation Seats in Support of Military Vehicle Crew Survivability Programs Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company") announced today that its subsidiary Med-Eng, LLC has been awarded two contracts with values of $74.6 million and $11.8 million by General Dynamics European Land Systems (GDELS) to provide blast attenuation seats. Delivering best-in-class protection, the seats will be deployed in the upcoming production of Mowag EAGLE V 4x4 command and control vehicles, and the Mowag EAGLE V 6x6 medium protected ambulance military vehicles. Cadre President Brad Williams commented, "These contracts represent another major win for Ca

    3/10/26 7:43:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings to Announce Fourth Quarter and Full Year 2025 Earnings and 2026 Financial Guidance on March 10, 2026

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the fourth quarter that ended on December 31, 2025, on Tuesday, March 10, 2026, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, March 11, 2026, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To par

    2/24/26 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    SEC Filings

    View All

    SEC Form 10-K filed by Cadre Holdings Inc.

    10-K - Cadre Holdings, Inc. (0001860543) (Filer)

    3/10/26 4:19:19 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Cadre Holdings, Inc. (0001860543) (Filer)

    3/10/26 4:15:27 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SCHEDULE 13G filed by Cadre Holdings Inc.

    SCHEDULE 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/12/26 4:13:47 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Neutral to Underperform and set a new price target of $26.00

    8/13/25 8:01:40 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Buy to Neutral and set a new price target of $38.00

    6/13/25 7:45:51 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ROTH MKM reiterated coverage on Cadre Holdings with a new price target

    ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

    2/21/24 9:51:23 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO AND CHAIRMAN Kanders Warren B gifted 12,250 shares (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    12/29/25 4:15:16 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CHIEF FINANCIAL OFFICER Browers Blaine sold $894,849 worth of shares (20,435 units at $43.79), decreasing direct ownership by 24% to 63,142 units (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    12/16/25 4:15:25 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    PRESIDENT Williams Brad sold $1,031,760 worth of shares (24,000 units at $42.99), decreasing direct ownership by 30% to 54,719 units (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    12/12/25 4:15:36 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    11/12/24 9:50:14 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Cadre Holdings Inc.

    SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/14/24 7:58:49 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/12/24 4:15:31 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Financials

    Live finance-specific insights

    View All

    Cadre Holdings Reports Fourth Quarter and Full Year 2025 Financial Results

    Generated Annual Net Sales of $610.3 Million, Gross Margin of 42.5% and Net Income of $44.1 Million Achieved Record Annual Adjusted EBITDA for Third Consecutive Year Expects Full Year 2026 Net Sales of $736 to $758 Million and Adjusted EBITDA of $136 to $141 Million, Reflecting Year-Over-Year Growth of 22% and 24%, Respectively, at Midpoints Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the quarter and year ended December 31, 2025. Net sales of $1

    3/10/26 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings to Announce Fourth Quarter and Full Year 2025 Earnings and 2026 Financial Guidance on March 10, 2026

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the fourth quarter that ended on December 31, 2025, on Tuesday, March 10, 2026, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, March 11, 2026, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To par

    2/24/26 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Increases Dividend

    Declares Quarterly Dividend of $0.10 Per Share; ~5% Increase on Annualized Basis Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share, or $0.40 per share on an annualized basis, on the Company's common stock. On an annualized basis, the newly declared cash dividend represents an increase of 2 cents, or approximately 5%, over the previous annualized dividend of $0.38 per share. Cadre's dividend payment will be m

    1/20/26 4:42:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    View All

    Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

    1/13/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

    4/12/22 8:30:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

    VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

    4/7/22 8:05:00 AM ET
    $CDRE
    $SOLO
    Industrial Specialties
    Health Care
    Auto Manufacturing
    Consumer Discretionary